Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Jackson

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
British Journal of Clinical Pharmacology|January 1, 1984
The oral clearance and beta-adrenoceptor antagonist activity of propranolol after single dose are not related to debrisoquine oxidation phenotypeM S Lennard, P R Jackson, S Freestone, et al.
BMJ (Clinical Research Ed.)|August 14, 1998
Use of statins. Sheffield table is usefulL E Ramsay, E J Wallis, I U Haq, et al.
BMJ (Clinical Research Ed.)|January 23, 1998
Use of statins. Evidence on effectiveness is stronger for statins than for other treatmentsE J Wallis, L E Ramsay, W W Yeo, et al.
Journal of Cardiovascular Pharmacology|April 1, 1997
Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypesI G Chadwick, L O'Toole, A H Morice, et al.
British Journal of Clinical Pharmacology|June 1, 1984
The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranololM S Lennard, P R Jackson, S Freestone, et al.
The American Journal of Tropical Medicine and Hygiene|September 1, 1984
Restriction endonuclease analysis of Leishmania kinetoplast DNA characterizes parasites responsible for visceral and cutaneous diseaseP R Jackson, J A Wohlhieter, J E Jackson, et al.
Clinical Science (London, England : 1979)|November 1, 1996
No relation between angiotensin-converting enzyme gene polymorphism and dermal response to bradykinin in healthy subjectsI G Chadwick, M Kraskiewicz, W W Yeo, et al.
British Journal of Clinical Pharmacology|April 1, 1991
Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjectsR V Lewis, L E Ramsay, P R Jackson, et al.
Clinical Science (London, England : 1979)|October 1, 1996
Lipid-lowering for prevention of coronary heart disease: what policy now?I Ul Haq, L E Ramsay, D M Pickin, et al.
Lancet (London, England)|March 19, 1994
ACE inhibitors, cough, and geneticsI G Chadwick, W W Yeo, K S Higgins, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
British Journal of Clinical Pharmacology|January 1, 1984
The oral clearance and beta-adrenoceptor antagonist activity of propranolol after single dose are not related to debrisoquine oxidation phenotypeM S Lennard, P R Jackson, S Freestone, et al.
BMJ (Clinical Research Ed.)|August 14, 1998
Use of statins. Sheffield table is usefulL E Ramsay, E J Wallis, I U Haq, et al.
BMJ (Clinical Research Ed.)|January 23, 1998
Use of statins. Evidence on effectiveness is stronger for statins than for other treatmentsE J Wallis, L E Ramsay, W W Yeo, et al.
Journal of Cardiovascular Pharmacology|April 1, 1997
Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypesI G Chadwick, L O'Toole, A H Morice, et al.
British Journal of Clinical Pharmacology|June 1, 1984
The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranololM S Lennard, P R Jackson, S Freestone, et al.
The American Journal of Tropical Medicine and Hygiene|September 1, 1984
Restriction endonuclease analysis of Leishmania kinetoplast DNA characterizes parasites responsible for visceral and cutaneous diseaseP R Jackson, J A Wohlhieter, J E Jackson, et al.
Clinical Science (London, England : 1979)|November 1, 1996
No relation between angiotensin-converting enzyme gene polymorphism and dermal response to bradykinin in healthy subjectsI G Chadwick, M Kraskiewicz, W W Yeo, et al.
British Journal of Clinical Pharmacology|April 1, 1991
Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjectsR V Lewis, L E Ramsay, P R Jackson, et al.
Clinical Science (London, England : 1979)|October 1, 1996
Lipid-lowering for prevention of coronary heart disease: what policy now?I Ul Haq, L E Ramsay, D M Pickin, et al.
Lancet (London, England)|March 19, 1994
ACE inhibitors, cough, and geneticsI G Chadwick, W W Yeo, K S Higgins, et al.
Pageof 14